MedQuist Holdings Inc. (NASDAQ/GS: MEDH), a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, announced today that Amy Dellamora Amick has been hired as Chief Operating Officer, and Michael Clark has been appointed Executive Vice President, Global Sales. As Chief Operating Officer, Amick will be charged with managing the company’s global service delivery, implementation and support, including consulting and professional services businesses. Overall operational management will be under her direction, along with process architecture execution and improvement. Before joining MedQuist, Amick served as General Manager, Worldwide Services for Microsoft’s Health Solutions Group where she was responsible for Microsoft’s global implementation, customer support, customer relationships and training and education. Prior to Microsoft, she served as Senior Vice President, Services for Allscripts Misys where she was accountable for implementation services, transformation services, Allscripts Academy (intra- and external training center) and warehouse operations. “We are excited to welcome Amy to the MedQuist leadership team,” said Vern Davenport, Chairman and CEO of MedQuist Holdings. “Our belief in Collaborative Intelligence requires our COO to understand not only how we as an organization can operate most effectively, but also how we can gain better synergies with our partners across the continuum of care. The healthcare industry is rapidly changing, and our leadership must understand the needs of healthcare across every dimension. Amy understands the drivers required for technology-enabled clinical documentation service leadership and the thought leadership for where the industry is heading tomorrow.” “I am thrilled to be joining the MedQuist team, especially at this point in the company’s evolution. We serve in an industry where the provision and support of healthcare services are fragmented. Both the technologies and the people within MedQuist are poised to make a true impact upon the evolution of the industry. I look forward to helping lead this journey,” said Amick.
Amick holds an MBA in management and strategy and information management from the Kellogg School of Management Studies at Northwestern University and BA in political science and leadership studies from the University of Richmond.Clark has held various executive leadership roles with MedQuist since joining the company in 1998, most recently directing the Company’s U.S. operational and sales responsibilities. He has facilitated key relationships with clients for clinical documentation improvement initiatives and has also set in motion the utilization of key technology to enhance service delivery. As Executive Vice President , Global Sales, Clark will lead an expanding new business sales force and also has responsibility for account management. "Michael's unparalleled knowledge of the industry, close client relationships and experienced thought leadership helped build the company as a leader in the transcription services industry today. We are fortunate to have him as a key player on our team, and we look forward to see his continued passion in his new role,” said Davenport. About MedQuist MedQuist is a leading provider of clinical narrative capture services, Speech Understanding technology from M*Modal and clinical documentation workflow. MedQuist's enterprise solutions – including mobile voice capture devices, speech recognition, Web-based workflow platforms and global network of medical editors – help healthcare facilities facilitate adoption of electronic health records (EHR), improve patient care, increase physician satisfaction and lower operational costs. For more information, please visit www.medquist.com. Forward-Looking Statements Information provided and statements contained in this press release that are not purely historical , such as statements regarding our operational improvement initiatives, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, specific factors discussed herein and in other releases and public filings made by the Company (including filings by the Company with the Securities and Exchange Commission). Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.